Literature DB >> 5808484

Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.

F Schaffner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5808484

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.

Authors:  Cynthia Levy; Keith D. Lindor
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

3.  Safe prescribing in liver disease.

Authors: 
Journal:  Br Med J       Date:  1973-04-28

4.  Clofibrate.

Authors:  A S Truswell
Journal:  Br Med J       Date:  1971-04-24

Review 5.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

6.  Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis.

Authors:  L A Turnberg; M P Mahoney; M H Gleeson; C B Freeman; A H Gowenlock
Journal:  Gut       Date:  1972-12       Impact factor: 23.059

Review 7.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.